Gut barrier failure in critical illness: Lessons learned from acute pancreatitis

Journal of Organ Dysfunction

Volumn 2, Issue 2, 2006, Pages 93-100

  Andersson, Roland ^a   Axelsson, Jakob ^a   Norrman, Gustav ^a   Wang, Xiangdong ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute pancreatitis; Critical illness; Gut barrier failure; MODS; SIRS

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ARGININE; CIPROFLOXACIN; GLUTAMINE; INSULIN; METRONIDAZOLE; OMEGA 3 FATTY ACID; PROBIOTIC AGENT; STEROID;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ACUTE PHASE RESPONSE; ANTIBIOTIC PROPHYLAXIS; BACTERIAL TRANSLOCATION; CRITICAL ILLNESS; ECOLOGY; ENTERITIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; INTESTINE FUNCTION; ISCHEMIA; MAJOR SURGERY; MICROCIRCULATION; MICROORGANISM; MULTIPLE ORGAN FAILURE; NUTRITION; PERMEABILITY; PRIORITY JOURNAL; REPERFUSION INJURY; RESUSCITATION; REVIEW; SEPTIC SHOCK;

EID: 33745114419     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060500233034     Document Type: Review

References (83)

1. Andersson R, Andersson B, Haraldsen P, Drewsen G, Eckerwall G. Incidence, management and recurrence rate of acute pancreatitis. Scand J Gastroenterol 2004;39:891-4.
2. Appelros S, Borgström A. Incidence, aetiology, and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg 1999;86:465-70.
3. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland 1984-1995. Br J Surg 1999;86:1382-5.
4. Ashley SW, Perez A, Pierce EA, Brooks DC, Moore FD Jr, Whang EE, et al. Necrotizing pancreatitis: contemporary analysis of 99 consecutive cases. Ann Surg 2001;234:572-9.
5. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg 1997;21:130-5.
6. Halonen KI, Pettila V, Leppaniemi AK, Kemppainen EA, Puolakkainen PA, Haappiainen RK. Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med 2002;30:1274-9.
7. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985;202:685-93.
8. Tran DD, Cuesta MA, van Leeuwen PA, Nauta JI, Wesdorp RE. Risk factors for multiple organ-system failure and death in critically injured patients. Surgery 1993;114:21-30.
9. de Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KCH. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-53.
10. McKay CJ, Gallagher G, Brooks C, Imrie CW, Baxter JM. Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83:919-23.
11. Lundberg AH, Granger N, Russell J, Sabek O, Henry J, Gaber L, et al. Quantitative measurement of P- and E-selectin adhesion molecules in acute pancreatitis: correlation with distant organ injury. Ann Surg 2000;231:213-22.
12. Blum T, Maisonneuve P, Lowenfels AB, Lankisch BG. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology 2001;1:237-41.
13. Beger HG, Bittner R, Bloch S, Büchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986;91:433-41.
14. Lumsden A, Bradley EL III. Secondary pancreatic infections. Surg Gynecol Obstet 1990;81:180-91.
15. Bradley EL, Aller K. A prospective longitudinal study of obstruction vs surgical intervention in the management of necrotizing pancreatitis. Am J Surg 1991;161:19-21.
16. Ogawa M. Acute pancreatitis and cytokines: "second attack" by septic complications lead to organ failure. Pancreas 1998;3:312-5.
17. Foitzik T. The enteral factor in pancreatic infection. Pancreatology 2001;1:217-23.
18. Goris RJA. Pathophysiology in shock and trauma. Eur J Surg 2000;166:100-11.
19. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 1993;218:111-9.
20. Wang XD, Andersson R, Soltesz V, Leveau P, Ihse I. Gut origin sepsis, macrophage function and oxygen extraction in acute pancreatitis in the rat. World J Surg 1996;20:299-308.
21. Andersson R, Sun ZW, Wang XD, Deng XM, Soltesz V, Ihse I. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats. Pancreas 1998;17:107-9.
22. Andersson R, Andersson E, Axelsson J. Gut barrier and gut inflammatory states in acute pancreatitis [review]. Archives of Hellenic Medicine 2003;20(Suppl A):61-7.
23. Wang XD, Andersson R. Intestinal brush-border membrane function. Scand J Gastroenterol 1994;29:289-99.
24. Andersson R, Wang XD. Gut barrier dysfunction in experimental acute pancreatitis. Ann Acad Med Singapore 1999;28:141-6.
25. Werner J, Z'gragen K, Fernandez-del Castillo C, Lewandrowski KV, Compton CC, Warshaw AL. Specific therapy for local and systemic complication of acute pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg 1999;226:834-42.
26. Ammori BJ, Leeder BC, King RF, Barclay GR, Martin IG, Larvin M, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis with endotoxemia, organ failure, and mortality. J Gastrointest Surg 1999;3:252-62.
27. Juvonen PO, Alhava EM, Takala JA. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol 2000;35:1314-8.
28. Wang XD, Andersson R. The role of endothelial cells in the systemic inflammatory response syndrome and multiple system organ failure. Eur J Surg 1995;161:703-13.
29. MacFadden DW. Organ failure and multiple organ system failure in pancreatitis. Pancreas 1991;6:S37-43.
30. Leveau P, Wang XD, Soltesz V, Ihse I, Andersson R. Alterations in intestinal motility and microflora in experimental acute pancreatitis. Int J Pancreatol 1996;20:119-25.
31. Satoh A, Shimosegawa T, Fujiita M, Kimura K, Masamune A, Koizumi M, et al. Inhibition of nuclear factor-κB improves the survival of rats with taurocholate pancreatitis. Gut 1999;44:253-8.
32. Algül H, Tando Y, Schneider G, Weidenbach H, Adler G, Schmid RM. Acute experimental pancreatitis in NF-κB/Rel activation. Pancreatology 2002;2:503-9.
33. Ethridge RT, Hashimoto K, Chung DH, Ehlers RA, Rajarajam S, Evers BM. Selective inhibition of NF-κB attenuates the severity of cerulein. J Am Coll Surg 2002;195:497-505.
34. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998;175:76-83.
35. Norman J. New approaches to acute pancreatitis: role of inflammatory mediators. Digestion 1999;60(Suppl 1):57-60.
36. Osman MO, Jensen SL. Acute pancreatitis: the pathophysiological role of cytokines and integrins - new trends for treatment? Dig Surg 1999;16:347-62.
37. Dib M, Zhao X, Wang XD, Andersson R. The role of mast cells in the development of pancreatitis-induced multiple organ dysfunction. Br J Surg 2002;89:172-8.
38. Magnotti LJ, Xu DZ, Lu Q, Deitch EA. Gut-derived mesenteric lymph. A link between burn and lung injury. Arch Surg 1999;134:1333-41.
39. Adams CA Jr, Sambol JT, Xu DZ, Lu Q, Granger N, Deitch EA. Hemorrhagic shock induced by up-regulation of P-selectin expression is mediated by factors in mesenteric lymph and blunted by mesenteric lymph duct interruption. J Trauma 2001;51:625-32.
40. Adams CA Jr, Hauser CJ, Adams JM, Fekete Z, Xu DZ, Sambol JT, Deitch EA. Trauma-hemorrhage-induced neutrophil priming is prevented by mesenteric lymph duct ligation. Shock 2002;19:513-7.
41. Menger MD, Plusczyk T, Vollmar B. Microcirculatory derangements in acute pancreatitis. J Hepatobil Pancr Surg 2001;8:187-94.
42. Wang XD, Sun ZW, Börjesson A, Andersson R. Inhibition of platelet-activating factor, intracellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 reduces experimental pancreatitis- associated gut endothelial barrier dysfunction. Br J Surg 1999;6:411-6.
43. Bonham MJ, Abu-Zidan FM, Simovic MO, Sluis KB, Wilkinson A, Winterbourn CC, et al. Early ascorbic acid depletion is related to the severity of acute pancreatitis. Br J Surg 1999;86:1296-301.
44. Schultz HU, Niederau C, Klonowski-Stumpe H, Hallangk W, Luthen R, Lippert H. Oxidative stress in acute pancreatitis. Hepatogastroenterology 1999;46:2736-50.
45. Rau B, Poch B, Gansauge F, Bauer A, Nussler AK, Nevalainen T, et al. Pathophysiologic role of oxygen-free radicals in acute pancreatitis: initiating event of mediator or tissue damage? Ann Surg 2000;231:352-60.
46. Wang XD, Deng XM, Haraldsen P, Andersson R, Ihse I. Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in rats. Scand J Gastroenterol 1995;30:1129-36.
47. Eckerwall G, Andersson R. Early enteral nutrition in severe acute pancreatitis. A way of providing nutrients, gut barrier protection, immunomodulation, or all of them? Scand J Gastroenterol 2001;36:449-58.
48. MacFie J. Enteral versus parenteral nutrition: the significance of bacterial translocation and gut-barrier function. Nutrition 2000;16:606-11.
49. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999;86:1020-4.
50. Gloor B, Müller CA, Worni M, Martignoni ME, Uhl W, Büchler MW. Late mortality in patients with severe acute pancreatitis. Br J Surg 2001;88:975-9.
51. Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: meta-analysis. J Gastrointest Surg 1998;2:496-503.
52. Bassi C, Mangiante G, Falconi M, Salvi R, Frigerio I, Pederzoli P. Prophylaxis for septic complications in acute necrotizing pancreatitis. J Hepatobil Pancr Surg 2001;8:211-5.
53. Powell JI, Miles R, Siriwardena AK. Antibiotic prophylaxis in the initial management of severe acute pancreatitis. Br J Surg 1998;85:582-7.
54. Gloor B, Muller CA, Worni M, Stahel PF, Redaelli C, Uhl W, Büchler MW. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001;136:592-6.
55. Isenmann R, Schwarz M, Rau B, Trautmann M, Schober W, Beger HG. Characteristicis of infection with Candida species in patients with necrotizing pancreatitis. World J Surg 2002;25:372-6.
56. Isenmann R, Rünzi M, Kron M, Kahl S, Kraus D, Jung N, et al. German Antibiotics in Severe Acute Pancreatitis (ASAP) Study Group. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 2004;126:997-1004.
57. Mangiante G, Colucci G, Canepari P, Bassi C, Nicoli N, Casari L, et al. Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Dig Surg 2001;18:47-50.
58. Olàh A, Belàgyi T, Issekutz À, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fiber supplement to early nutrition in patients with acute pancreatitis. Br J Surg 2002;89:1103-7
59. Kalfarentzos F, Kehagias N, Mead K, Kokkinis K, Gogos CA. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997;84:665-9.
60. Windsor AC, Kanwar S, Li AG, Barnes E, Guthrie JA, Spark JI, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998;42:431-5.
61. Olàh A, Pardavi G, Belàgyi T, Nagy A, Issekutz À, Mohamed GE. Early nasojejunal feeding in acute pancreatitis is associated with low complication rate. Nutrition 2002;18:259-62.
62. Heyland DK, Novak F, Drover JW, Jayn M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001;286:944-53.
63. Eatock FC, Brombacher GD, Steven A, Imrie CW, McKay CJ, Carter R. Nasogastric feeding in severe acute pancreatitis may be practical and safe. Int J Pancreatol 2000;28:23-9.
64. Eatock FC, Chong P, Menezes N, Murray L, McKay CJ, Carter CR, Imrie CW. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol 2005;100:432-9.
65. Alexander JW. Nutritional pharmacology in surgical patients [review]. Am J Surg 2002;183:349-52.
66. Rhoads JM, Argenzio RA, Chen W, Rippe RA, Westwick JK, Cox AD, et al. L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 1997;272:G943-53
67. Alexander JW. Immunonutrition: the role of omega-3 fatty acids [review]. Nutrition 1998;14:627-33.
68. Jyonouchi H. Nucleotide actions on humoral immune responses. J Nutr 1994;124(1 Suppl):138-43S.
69. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence [review]. Crit Care Med 2002;30:2022-9.
70. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997;13:295-302.
71. Jones C, Palmer TA, Griffiths RD. A randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition 1999;15:108-15.
72. Esmon CT. The normal role of activated protein C in maintaining homeostasis and its relevance to critical illness. Crit Care 2000;5:S7-12.
73. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
74. van den Berghe G, Wouters P, Weckers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
75. Mayer K, Grimm H, Grimminger F, Seeger W. Parenteral nutrition with n-3 lipids in sepsis. Br J Nutr 2002;87(Suppl 1):S69-75.
76. Gianotti L, Braga M, Vignali A, Balzano G, Zerbi A, Bisagni P, Di Carlo V. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997;132:1222-30.
77. Senkal M, Mumme A, Eickhoff U, Geier B, Spath G, Wulfert D, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997;25:1489-96.
78. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999;27:2799-805.
79. Gianotti L, Braga M, Frei A, Greiner R, Di Carlo V. Health care resources consumed to treat postoperative infections: cost saving by perioperative immunonutrition. Shock 2000;14:325-30.
80. McCowen KC, Bistrian BR. Immunonutrition: problematic or problem solving? [review]. Am J Clin Nutr 2003;77:764-70.
81. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
82. Creasey AA, Reinhart K. Tissue factor pathway inhibitor activity in severe sepsis [review]. Crit Care Med 2001;29(7 Suppl):S126-9.
83. Akahane K, Okamoto K, Kikuchi M, Todoroki H, Higure A, Ohuchida T, et al. Inhibition of factor Xa suppresses the expression of tissue factor in human monocytes and lipopolysaccharide-induced endotoxemia in rats. Surgery 2001;130:809-18.